Syensqo Invests in Green Solvents Start-Up Bioeutectics
Syensqo Ventures, the group’s venture capital fund, participated in the €1.9 million ($2.1 million) financing round for Bioeutectics, alongside Fen Ventures, Atento Capital, and SOSV (IndieBio).
This new investment strengthens the existing partnership between Syensqo Ventures and the Genesis Consortium, supporting startups in the SOSV’s IndieBio startup development program, the #1 early-stage biotech incubator.
“We see a growing demand for efficient and environmentally friendly solvents, which can also be biodegradable, non-toxic, and affordable. Bioeutetics’ cutting-edge technology is at the forefront of solvent innovation, combining high-performance, quality, and sustainability that could bring real added value to Syensqo’s portfolio of products,” commented Jean-Christophe Castaing, Global R&I Director, New Technologies at Syensqo.
Bioeutectics, founded in 2019, provides natural and high-performance solvents that make industrial products and processes more sustainable. Based on Natural Deep Eutectic Solvents (NADES), Bioeutetics mimics the way plants elaborate their solvents, using 100% renewable sources as opposed to petrochemical-based solvents.
"We are excited to have Syensqo onboard to help us bring these early-stage innovations to the market. Syensqo’s expertise in solvents and formulation is key to our success,” said Tomas Silicaro, CEO of Bioeutectics.
